NCT06567028

Brief Summary

An OSPM-enhanced deep learning model has been developed for identifying premalignant and malignant tumors using data retrospectively collected from the Ningbo Eye Hospital, Jiangdong Eye Hospital, and the Eye Hospital of Wenzhou Medical University. To further substantiate the model's effectiveness, we intend to evaluate it prospectively at Ningbo Eye Hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

August 20, 2024

Last Update Submit

March 23, 2025

Conditions

Performance of the Model

Outcome Measures

Primary Outcomes (1)

  • AUROC

    area under the receiver operating characteristic curve

    3 months

Interventions

OSPM-Enhanced AI ModelDIAGNOSTIC_TEST

Analyze tumor images using the model developed in our study

Eligibility Criteria

Age1 Year - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Child, Adult, Older Adult

You may qualify if:

  • ● Ocular surface tumor images with histopathological findings

You may not qualify if:

  • ● Low-quality images

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo Eye Hospital

Ningbo, Zhejiang, 315040, China

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2024

First Posted

August 22, 2024

Study Start

June 1, 2024

Primary Completion

October 1, 2024

Study Completion

November 1, 2024

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)